Literature DB >> 19235914

Genetic epistasis of IL23/IL17 pathway genes in Crohn's disease.

Dermot P B McGovern1, Jerome I Rotter, Ling Mei, Talin Haritunians, Carol Landers, Carrie Derkowski, Deb Dutridge, Marla Dubinsky, Andy Ippoliti, Eric Vasiliauskas, Emebet Mengesha, Lily King, Sheila Pressman, Stephan R Targan, Kent D Taylor.   

Abstract

BACKGROUND: The IL23/IL17 pathway is pivotal in the development of chronic mucosal inflammation seen in Crohn's disease (CD). Genetic variants in the IL23R and IL12B have been associated with CD susceptibility. We investigated 10 genes within the IL23/IL17 pathway in a case-control study of 763 CD cases and 254 healthy controls.
METHODS: We identified a novel association in haplotypes in IL17A (empirical P = 0.02), IL17RA (P = 0.001), IL17RD (P = 0.001), IL12RB1 (P = 0.003), and IL12RB2 (P = 0.001) as well as confirming the association with IL12B variants (P = 0.003).
RESULTS: The cumulative risk for carrying an increased number of CD risk haplotypes from genes in this pathway rises to an odds ratio of 4.3 for carrying 5 risk haplotypes. We have previously demonstrated an association between this cohort and IL23R haplotypes. Pairwise analyses suggest that there is statistical interaction between variants in IL17A and IL23R (P = 0.047) and between variants in IL17RA and IL23R (P = 0.036). Furthermore, a significant association between CD and the widely replicated IL23R variants is only seen in the presence of IL17A or IL17RA variants.
CONCLUSIONS: These data support the investigation of pathways implicated in CD pathogenesis in order to identify further susceptibility genes and also suggest that important gene-gene interaction is present in CD susceptibility.(Inflamm Bowel Dis 2009).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19235914      PMCID: PMC2916929          DOI: 10.1002/ibd.20855

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  26 in total

1.  The International HapMap Project.

Authors: 
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

Review 2.  Genetics, statistics and human disease: analytical retooling for complexity.

Authors:  Tricia A Thornton-Wells; Jason H Moore; Jonathan L Haines
Journal:  Trends Genet       Date:  2004-12       Impact factor: 11.639

3.  IL23R haplotypes provide a large population attributable risk for Crohn's disease.

Authors:  Kent D Taylor; Stephan R Targan; Ling Mei; Andrew F Ippoliti; Dermot McGovern; Emebet Mengesha; Lily King; Jerome I Rotter
Journal:  Inflamm Bowel Dis       Date:  2008-09       Impact factor: 5.325

4.  Increased expression of interleukin 17 in inflammatory bowel disease.

Authors:  S Fujino; A Andoh; S Bamba; A Ogawa; K Hata; Y Araki; T Bamba; Y Fujiyama
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

5.  Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews.

Authors:  M P Roth; G M Petersen; C McElree; C M Vadheim; J F Panish; J I Rotter
Journal:  Gastroenterology       Date:  1989-04       Impact factor: 22.682

Review 6.  A general overview of Mantel-Haenszel methods: applications and recent developments.

Authors:  S J Kuritz; J R Landis; G G Koch
Journal:  Annu Rev Public Health       Date:  1988       Impact factor: 21.981

7.  Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews.

Authors:  H Yang; C McElree; M P Roth; F Shanahan; S R Targan; J I Rotter
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

8.  Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12.

Authors:  B Oppmann; R Lesley; B Blom; J C Timans; Y Xu; B Hunte; F Vega; N Yu; J Wang; K Singh; F Zonin; E Vaisberg; T Churakova; M Liu; D Gorman; J Wagner; S Zurawski; Y Liu; J S Abrams; K W Moore; D Rennick; R de Waal-Malefyt; C Hannum; J F Bazan; R A Kastelein
Journal:  Immunity       Date:  2000-11       Impact factor: 31.745

9.  A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews.

Authors:  Kazuhito Sugimura; Kent D Taylor; Ying-chao Lin; Tieu Hang; Dai Wang; Yong-Ming Tang; Nathan Fischel-Ghodsian; Stephan R Targan; Jerome I Rotter; Huiying Yang
Journal:  Am J Hum Genet       Date:  2003-02-07       Impact factor: 11.025

10.  Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease.

Authors:  William S Mow; Eric A Vasiliauskas; Ying-Chao Lin; Phillip R Fleshner; Konstantinos A Papadakis; Kent D Taylor; Carol J Landers; Maria T Abreu-Martin; Jerome I Rotter; Huiying Yang; Stephan R Targan
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

View more
  36 in total

1.  Interaction between CTLA4 gene and IBD5 locus in Hungarian Crohn's disease patients.

Authors:  Veronika Csöngei; Luca Járomi; Eniko Sáfrány; Csilla Sipeky; Lili Magyari; Noémi Polgár; Judit Bene; Patrícia Sarlós; Lilla Lakner; Eszter Baricza; Melinda Szabó; Gábor Rappai; Béla Melegh
Journal:  Int J Colorectal Dis       Date:  2011-04-26       Impact factor: 2.571

2.  Pattern recognition receptor and autophagy gene variants are associated with development of antimicrobial antibodies in Crohn's disease.

Authors:  Travis B Murdoch; Wei Xu; Joanne M Stempak; Carol Landers; Stephan R Targan; Jerome I Rotter; Mark S Silverberg
Journal:  Inflamm Bowel Dis       Date:  2012-01-24       Impact factor: 5.325

3.  Effect of IL12A and IL12B polymorphisms on the risk of Chlamydia trachomatis-induced tubal factor infertility and disease severity.

Authors:  H Ohman; R Bailey; A Natividad; J Ragoussis; L-L Johnson; A Tiitinen; M Halttunen; J Paavonen; H-M Surcel
Journal:  Hum Reprod       Date:  2012-05-11       Impact factor: 6.918

Review 4.  The IL-17 family cytokines in immunity and disease.

Authors:  Rajita Pappu; Vladimir Ramirez-Carrozzi; Naruhisa Ota; Wenjun Ouyang; Yan Hu
Journal:  J Clin Immunol       Date:  2010-02-23       Impact factor: 8.317

Review 5.  The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases.

Authors:  Rajita Pappu; Vladimir Ramirez-Carrozzi; Arivazhagan Sambandam
Journal:  Immunology       Date:  2011-07-04       Impact factor: 7.397

Review 6.  IL-35 and Autoimmunity: a Comprehensive Perspective.

Authors:  Jinjung Choi; Patrick S C Leung; Christopher Bowlus; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 8.667

Review 7.  Cytokines, IBD, and colitis-associated cancer.

Authors:  Ralph Francescone; Vivianty Hou; Sergei I Grivennikov
Journal:  Inflamm Bowel Dis       Date:  2015-02       Impact factor: 5.325

8.  Susceptibility to ulcerative colitis in Hungarian patients determined by gene-gene interactions.

Authors:  Patricia Sarlos; Dalma Varszegi; Veronika Csongei; Lili Magyari; Luca Jaromi; Lajos Nagy; Bela Melegh
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

9.  Molecular reclassification of Crohn's disease by cluster analysis of genetic variants.

Authors:  Isabelle Cleynen; Jestinah M Mahachie John; Liesbet Henckaerts; Wouter Van Moerkercke; Paul Rutgeerts; Kristel Van Steen; Severine Vermeire
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

10.  A systems model for immune cell interactions unravels the mechanism of inflammation in human skin.

Authors:  Najl V Valeyev; Christian Hundhausen; Yoshinori Umezawa; Nikolay V Kotov; Gareth Williams; Alex Clop; Crysanthi Ainali; Christos Ouzounis; Sophia Tsoka; Frank O Nestle
Journal:  PLoS Comput Biol       Date:  2010-12-02       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.